GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Stevanato Group SpA (MEX:STVN N) » Definitions » 3-Year Book Growth Rate

Stevanato Group SpA (MEX:STVN N) 3-Year Book Growth Rate : 14.40% (As of Mar. 2025)


View and export this data going back to 2022. Start your Free Trial

What is Stevanato Group SpA 3-Year Book Growth Rate?

Stevanato Group SpA's Book Value per Share for the quarter that ended in Mar. 2025 was MXN114.75.

During the past 12 months, Stevanato Group SpA's average Book Value per Share Growth Rate was 5.80% per year. During the past 3 years, the average Book Value per Share Growth Rate was 14.40% per year. During the past 5 years, the average Book Value per Share Growth Rate was 43.10% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average Book Value per Share growth rate.

During the past 7 years, the highest 3-Year average Book Value per Share Growth Rate of Stevanato Group SpA was 60.00% per year. The lowest was 14.40% per year. And the median was 57.10% per year.

Competitive Comparison of Stevanato Group SpA's 3-Year Book Growth Rate

For the Medical Instruments & Supplies subindustry, Stevanato Group SpA's 3-Year Book Growth Rate, along with its competitors' market caps and 3-Year Book Growth Rate data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Stevanato Group SpA's 3-Year Book Growth Rate Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Stevanato Group SpA's 3-Year Book Growth Rate distribution charts can be found below:

* The bar in red indicates where Stevanato Group SpA's 3-Year Book Growth Rate falls into.


;
;

Stevanato Group SpA 3-Year Book Growth Rate Calculation

This is the 3-year average growth rate of Book Value per Share. The growth rate is calculated using exponential compounding based on the latest four year annual data.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average Book Value per Share growth rate.

Stevanato Group SpA  (MEX:STVN N) 3-Year Book Growth Rate Explanation

Book Value per Share is the ratio of equity available to common shareholders divided by the shares outstanding. Book value per share effectively indicates a firm's net asset value on a per-share basis. It can be used by investors to gauge whether a stock price is undervalued by comparing it to the firm's market value per share. Theoretically, it is what the shareholders will receive if the company is liquidated.

Stevanato Group SpA 3-Year Book Growth Rate Related Terms

Thank you for viewing the detailed overview of Stevanato Group SpA's 3-Year Book Growth Rate provided by GuruFocus.com. Please click on the following links to see related term pages.

Stevanato Group SpA Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Stevanato Group SpA (MEX:STVN N) » Definitions » 3-Year Book Growth Rate
Comparable Companies
RGEN MMSI TFX AVTR NVST ICUI XRAY ATR WRBY LMAT ISRG XPAR:EL BDX XSWX:ALC TSE:7741 RMD TSE:4543 XPAR:DIM OCSE:COLO B XSWX:STMN
Traded in Other Exchanges
STVN:USA 87N:Germany
Address
Via Molinella 17, Piombino Dese, Padua, ITA, 35017
Website
https://www.stevanatogroup.com
Stevanato Group SpA is a provider of drug containment, drug delivery and diagnostic solutions to the pharmaceutical, biotechnology and life sciences industries. It delivers an integrated, end-to-end portfolio of products, processes, and services that address customer needs across the entire drug life cycle including development, clinical, and commercial stages. It has two segments; Biopharmaceutical and Diagnostic Solutions which generates key revenue, includes all the products, processes and services developed and provided for the containment and delivery of pharmaceutical and biotechnology drugs and reagents, as well as the production of diagnostic consumables and its other segment is Engineering. Geographically, the company derives majority revenue from Europe, Middle East and Africa.

Stevanato Group SpA Headlines

No Headlines